BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2019
View Archived Issues
Novel pgm2 gene knockout mouse model of PGM1-CDG
Read More
APOE4 strongly affects microglial function
Read More
Jacobio recruiting patients with advanced solid tumors for phase I study of JAB-3312
Read More
Nitazoxanide amplifies RNA sensor and type I interferon activities and inhibits Ebola virus
Read More
Getting to the root of schizophrenia
Read More
First patient dosed in phase I study of KO-539 for AML
Read More
Precision BioSciences announces FDA clearance of IND for PBCAR-20-A
Read More
Preliminary clinical data presented from U.S. phase II study of ANAVEX 2-73 in Rett syndrome
Read More
Discovery of novel PS-targeting zinc dipicolylamine-based drug conjugates
Read More
YK-4-279 and TK-216 show promising preclinical activity in models of lymphoma
Read More
miR-744 found to be a prognostic factor in NSCLC
Read More
B cells, T cells honored as hybrids reported
Read More
Phase II data presented for selatogrel in patients with acute myocardial infarction
Read More
Stanford University patents GPAM inhibitors
Read More
Sumitomo Dainippon Pharma presents dopamine D1 and D2 receptor antagonists
Read More
DE Shaw Research and Relay Therapeutics describe new PTP-1D inhibitors
Read More
Newave Pharmaceutical identifies WEE1hu inhibitors
Read More
Boehringer Ingelheim synthesizes new EGFR mutant inhibitors
Read More
Edoxaban in atrial fibrillation patients after PCI: Results from ENTRUST-AF PCI
Read More
CARB-X to fund Procarta's development of new class of antibiotics targeting ESKAPE pathogens
Read More
Acceleron ends development of ACE-083 for facioscapulohumeral muscular dystrophy
Read More
DSMC recommends continuation of U.S. study of IDCT for degenerative disc disease
Read More
Phase III PREVENT trial of Cosentyx in nr-axSpA meets 16-week primary endpoint
Read More
Neuronascent studies NNI-362 in healthy aged volunteers in first-in-human trial
Read More
Life Molecular Imaging opens enrollment for phase II trial of next-generation tau PET tracer PI-2620
Read More